Cosmetic Labeling Requirements Checklist

Labeling errors are among the most frequent compliance issues for indie and scaling beauty brands. A product may be perfectly formulated yet still misbranded if the principal display panel omits required elements or if the ingredient list uses non-INCI names. A systematic checklist review before print runs and website launch reduces costly recalls and marketplace delistings.

What must appear on the principal display panel?

The principal display panel is the part of the label most likely displayed to consumers at retail. It must include an identity statement describing the nature and use of the product — such as "moisturizer" or "shampoo" — and a net quantity statement showing how much product is in the package in both metric and U.S. customary units for products sold in the United States. FDA Cosmetics Labeling Guide provides detailed formatting requirements for cosmetic labels.

How should ingredient lists be formatted?

Ingredients must appear on the information panel in descending order of predominance before the product is used by the consumer. FDA expects standardized INCI names in most cases. Color additives may follow special naming conventions. Fragrance and flavor ingredients may be listed collectively as "fragrance" or "flavor," but allergens and certain claims may trigger additional disclosure obligations under state or international rules beyond FDA minimums.

• List ingredients using accepted INCI nomenclature unless an exception applies.
• Place the ingredient declaration on an information panel in a conspicuous location.
• Ensure type size and contrast meet readability expectations for panel size.
• Match label ingredients to master formula and batch records.
• Update labels when formulation changes — do not rely on outdated print files.

What responsible party information is required?

The label must identify the name and place of business of the manufacturer, packer, or distributor. If the responsible party is not the manufacturer, the relationship should be clear — for example, "Manufactured for" or "Distributed by." Contact information helps FDA and consumers identify who stands behind the product.

When are warning statements required on cosmetic labels?

Some products require specific warnings under FDA regulations — for example, certain aerosols or products where safety testing indicates irritation risk. Even when not mandatory, voluntary warnings may be prudent when usage instructions involve eye area application, sun sensitivity, or patch testing. Claims on the label can also change regulatory classification if they imply drug benefits.

What common cosmetic labeling mistakes trigger FDA attention?

Frequent issues include drug claims on cosmetic labels — such as "repairs skin disease" or "eliminates acne" — missing net weight on the principal display panel, incorrect ingredient order, and unsubstantiated "clean," "natural," or "hypoallergenic" implications that mislead consumers. Marketing copy on websites and influencer posts is reviewed alongside physical labels when FDA evaluates misbranding.

Cosmetics vs. drugs: labeling consequences

Products intended to affect structure or function beyond cleansing, beautifying, or altering appearance may be drugs, drug-cosmetic combinations, or cosmetics with drug claims requiring different labeling and approval pathways. Natascia Taken, Esq. recommends reviewing claims holistically so outer cartons, inserts, and digital shelf copy align with the product's intended regulatory category.

Should brands review labels before each production run?

Yes. Establish a pre-press approval workflow involving regulatory review, artwork verification, and a final comparison against the approved master label. Retailers and marketplaces increasingly request certificates or label PDFs during onboarding. Keeping version-controlled label records simplifies audits and speeds response if FDA or a retailer raises questions.

What changed under the Modernization of Cosmetics Regulation Act (MoCRA)?

MoCRA expanded FDA authority over cosmetic safety, facility registration, product listing, serious adverse event reporting, and records access. While many traditional labeling elements remain familiar, brands should confirm whether new facility and product listing obligations apply to their operations. MoCRA does not replace fundamental misbranding rules but adds operational compliance layers many companies had not previously managed.

How should brands handle dual-language or export labels?

Products sold in the U.S. must meet FDA English labeling requirements unless a specific exception applies. Dual-language labels are permitted when all required information appears in English and remains prominent. Export-only labeling cannot be sold domestically without U.S.-compliant labels. Natascia Taken, Esq. often reviews international label adaptations to ensure U.S. e-commerce listings do not display non-compliant artwork.

What should brands verify on secondary packaging and inserts?

Claims on cartons, leaflets, and QR-linked landing pages must align with the principal label and comply with the same misbranding rules. A compliant front label does not cure drug claims on an insert directing consumers to a disease-treatment landing page. Review the full unboxing experience, not just the primary panel submitted to a retailer.

Shelf talkers, sample sachets, and subscription refill inserts are easy to overlook during label review but count as labeling when they accompany the product at point of sale.

This checklist summarizes general FDA cosmetic labeling concepts for educational purposes and is not legal advice. State laws, MoCRA requirements, and international markets may impose additional obligations.